NIH News Advisory
NATIONAL INSTITUTES OF HEALTH
Office of the Director

EMBARGOED FOR RELEASE
Friday, April 9, 1999

Contact: Marc Stern
(301) 496-2535

NIH/FDA Meeting on Biomarkers and Surrogate Endpoints

What: NIH/FDA Meeting Will Explore Biomarkers and Surrogate Endpoints:
Advancing Clinical Research and Applications
When: Thursday, April 15, 1999, beginning at 8:00 a.m. and
Friday, April 16, 1999, beginning at 7:45 a.m.
Where: NIH Natcher Conference Center (Building 45) Bethesda, MD
Why: This forum will address the research needs and scientific opportunities to develop and apply biomarkers for safety and efficacy evaluations of novel disease interventions. The meeting will emphasize the application of fundamental biology and emerging technologies for clinical assessment. Presentations will focus on concepts and approaches for the use of biomarkers in early drug development and as surrogate endpoints in clinical trials.